Remdesivir has more than one mechanism for treating patients with COVID-19, according to new research from the U of A
Published recently in the Journal of Biological Chemistry, University of Alberta researchers released findings that the antiviral drug remdesivir has more uses than originally thought in the fight against COVID-19. Previously established as a drug that stops the virus from replicating, the U of A research team discovered it can also prevent or delay the virus from spreading within the body.
Remdesivir currently has conditional approval from Health Canada for use in adults and adolescents with severe COVID-19 symptoms. The drug is administered intravenously and can only be used under the supervision of a healthcare provider.
"Remdesivir speeds up the time of recovery from 15 to 11 days. These randomized clinical trials, this is the gold standard to evaluate antiviral drugs," said U of A Professor Matthias Gotte, chair of medical microbiology and immunology.
Clinical trials of remdesivir are ongoing. Studies like this help doctors know how the drug can work in combination with others, and helps researchers get a better sense of how other treatments could work against COVID-19. Once a vaccine is found, treatment drugs such as remdesivir will still be important, as not everyone will be immunized right away.
Source: CBC Edmonton